Chemoinformaics analysis of 7-Prenyloxycoumarin
| Molecular Weight | 230.263 | nRot | 3 |
| Heavy Atom Molecular Weight | 216.151 | nRig | 13 |
| Exact Molecular Weight | 230.094 | nRing | 2 |
| Solubility: LogS | -3.828 | nHRing | 1 |
| Solubility: LogP | 3.577 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 35.1211 |
| nHD | 0 | BPOL | 18.3849 |
| QED | 0.6 |
| Synth | 2.231 |
| Natural Product Likeliness | 0.93 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.04 |
| Pgp-sub | 0.038 |
| HIA | 0.004 |
| CACO-2 | -4.688 |
| MDCK | 0.0000205 |
| BBB | 0.038 |
| PPB | 0.883508 |
| VDSS | 1.236 |
| FU | 0.0921241 |
| CYP1A2-inh | 0.978 |
| CYP1A2-sub | 0.659 |
| CYP2c19-inh | 0.863 |
| CYP2c19-sub | 0.123 |
| CYP2c9-inh | 0.401 |
| CYP2c9-sub | 0.888 |
| CYP2d6-inh | 0.568 |
| CYP2d6-sub | 0.865 |
| CYP3a4-inh | 0.22 |
| CYP3a4-sub | 0.307 |
| CL | 14.407 |
| T12 | 0.259 |
| hERG | 0.067 |
| Ames | 0.221 |
| ROA | 0.061 |
| SkinSen | 0.282 |
| Carcinogencity | 0.786 |
| EI | 0.943 |
| Respiratory | 0.146 |
| NR-Aromatase | 0.043 |
| Antiviral | No |
| Prediction | 0.730001 |